Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

UCBJY UCB S.A. UNSP ADR EACH REPR 0.5 ORD

34.290
+0.490+1.45%
Close 09/28 16:00 ET
High
34.430
Open
33.550
Turnover
1.71M
Low
33.550
Pre Close
33.800
Volume
50.22K
Market Cap
13.03B
P/E(TTM)
14.35
52wk High
63.168
Shares
379.92M
P/E(Static)
11.07
52wk Low
32.820
Float Cap
13.03B
Bid/Ask %
0.00%
Historical High
63.168
Shs Float
379.92M
Volume Ratio
0.42
Historical Low
32.820
Dividend TTM
0.681
Div Yield TTM
0.715
P/B
1.51
Dividend LFY
1.99%
Div Yield LFY
2.09%
Turnover Ratio
0.01%
Amplitude
2.60%
Avg Price
33.981
Lot Size
1
Float Cap
13.03B
Bid/Ask %
0.00%
Historical High
63.168
Shs Float
379.92M
Volume Ratio
0.42
Historical Low
32.820
Dividend TTM
0.681
P/B
1.51
Dividend LFY
1.99%
Turnover Ratio
0.01%
Amplitude
2.60%
Avg Price
33.981
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
UCB SA engages in the research and development biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
CEO: Jean-Christophe Tellier
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...